Neurelis, Inc. is a San Diego-based pharmaceutical company specializing in the development and commercialization of innovative therapies for neurological disorders. With a strong focus on medical affairs and research, Neurelis is dedicated to providing personalized support for patients and care partners. Their pipeline includes NRL-1049 and NRL-4, utilizing advanced science and technologies to address unmet medical needs in the field.
As a leader in the industry, Neurelis collaborates with strategic partners to advance their mission of improving patient outcomes. With a commitment to ethical business conduct, Neurelis is known for its dedication to community involvement and the highest standards of quality. Their trademarks, including VALTOCO and MYNEURELIS, represent their commitment to innovation and excellence in the field of neurological therapeutics.
Generated from the website